vTv Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.1%.

Top 25 shareholders own 69.13% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
35.2%	MacAndrews & Forbes Incorporated	855,140	€16.6m	-6.34%	7.36%
10.7%	Group 42 Holding Ltd	259,657	€5.0m	0%	no data
8.5%	Samsara BioCapital LLC	206,784	€4.0m	406%	0.88%
5.55%	August Troendle	134,938	€2.6m	0%	no data
4%	Baker Bros. Advisors LP	97,314	€1.9m	0%	0.02%
2.38%	Ronald Perelman	57,842	€1.1m	-22.1%	no data
1.01%	The Vanguard Group, Inc.	24,558	€477.3k	4.42%	no data
0.6%	Paul Sekhri	14,686	€285.4k	-14.6%	no data
0.45%	Richard Nelson	10,876	€211.4k	625%	no data
0.24%	Geode Capital Management, LLC	5,903	€114.7k	0%	no data
0.21%	Steven Tuch	5,207	€101.2k	0%	no data
0.063%	John Fry	1,525	€29.6k	0%	no data
0.06%	UBS Asset Management AG	1,457	€28.3k	0%	no data
0.044%	BlackRock, Inc.	1,079	€21.0k	-19.5%	no data
0.035%	Morgan Stanley, Investment Banking and Brokerage Investments	840	€16.3k	0%	no data
0.026%	Chandresh Harjivan	625	€12.1k	0%	no data
0.026%	Hersh Kozlov	625	€12.1k	0%	no data
0.026%	Keith Harris	625	€12.1k	0%	no data
0.026%	Planning Capital Management Corp.	625	€12.1k	0%	0.01%
0.026%	Fahed Al-Marzooqi	625	€12.1k	0%	no data
0.022%	Tower Research Capital LLC	535	€10.4k	-50%	no data
0.0062%	Osaic Wealth, Inc. , Asset Management Arm	150	€2.9k	200%	no data
0.0043%	Royal Bank of Canada, Banking & Securities Investments	104	€2.0k	-81.4%	no data
0.0031%	Merrill Lynch & Co. Inc., Banking Investments	75	€1.5k	0%	no data
0.0016%	Parallel Advisors, LLC	38	€737.6	0%	no data